Androgenetic Alopecia and COVID-19: A Review of the Hypothetical Role of Androgens

    May 2021 in “ Dermatologic Therapy ”
    Hamideh Moravvej, Mohammad Reza Pourani, Moein Baghani, Fahimeh Abdollahimajd
    Studysummary This review discusses the potential link between androgenetic alopecia and COVID-19 severity, examining the role of androgens and relevant treatments, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 26

    1. Androgenetic Alopecia and COVID-19: A Review of the Hypothetical Role of Androgens Dermatologic Therapy · 2021
    2. Anti-Androgens May Protect Against Severe COVID-19 Outcomes: Results From a Prospective Cohort Study of 77 Hospitalized Men Journal of The European Academy of Dermatology and Venereology · 2021
    3. 5-Alpha-Reductase Inhibitors Are Associated With Reduced Frequency of COVID-19 Symptoms in Males With Androgenetic Alopecia Journal of The European Academy of Dermatology and Venereology · 2020
    4. Alopecia and Grey Hair Are Associated with COVID-19 Severity Experimental Dermatology · 2020
    5. Reply to Letter to the Editor: A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19' Journal of The American Academy of Dermatology · 2020
    6. A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19' Journal of The American Academy of Dermatology · 2020
    7. Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 Journal of the European Academy of Dermatology and Venereology · 2020
    8. Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial) Research Square (Research Square) · 2020
    9. Repurposing Existing Drugs for COVID-19: An Endocrinology Perspective BMC Endocrine Disorders · 2020
    10. Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients Journal of the European Academy of Dermatology and Venereology · 2020
    11. Androgen Deprivation Therapy May Be a More Effective COVID-19 Prophylactic Than Therapeutic Strategy Annals of Oncology · 2020
    12. Androgenetic Alopecia in COVID-19: Compared to What? Journal of The American Academy of Dermatology · 2020
    13. Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign Journal of The American Academy of Dermatology · 2020
    14. Male Balding Is a Major Risk Factor for Severe COVID-19 Journal of The American Academy of Dermatology · 2020
    15. Are Sex Discordant Outcomes in COVID-19 Related to Sex Hormones? Seminars in Oncology · 2020
    16. TMPRSS2, Required for SARS-CoV-2 Entry, Is Downregulated in Lung Cells by Enzalutamide, a Prostate Cancer Therapeutic Research Square (Research Square) · 2020
    17. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    18. Androgen Sensitivity Gateway to COVID-19 Disease Severity Drug Development Research · 2020
    19. Effects of 5-Alpha Reductase Inhibitors on Lung Function: A Reason for Discontinuation During COVID-19 Pandemic? Dermatologic Therapy · 2020
    20. Evaluation of the Efficacy and Safety of Cow Placenta Extract Lotion Versus Minoxidil 2% in the Treatment of Female Pattern Androgenetic Alopecia International Journal of Women's Dermatology · 2020
    21. Impact of Anti-Androgen Therapies on COVID-19 Susceptibility: A Case-Control Study in Male Population from Two COVID-19 Regional Centers of Lombardy, Italy medRxiv (Cold Spring Harbor Laboratory) · 2020
    22. May Patients Receiving 5-Alpha-Reductase Inhibitors Be at Higher Risk of COVID-19 Complications? Medical hypotheses · 2020
    23. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    24. Testosterone in COVID-19: Foe, Friend or Fatal Victim? touchREVIEWS in Endocrinology · 2020
    25. HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond Endocrinology · 2019
    26. Age-Related Hair Changes in Men: Mechanisms and Management of Alopecia and Graying Maturitas · 2014